News & Perspective

(CIDRAP News) – A comprehensive review of the nation's tools for reducing the impact of a biological weapons attack or other public health emergency—prompted in part by last fall's delays in delivery of the pandemic H1N1 vaccine—is due to get under way in the next few weeks with a pair of conferences.

(CIDRAP News) – The US Food and Drug Administration (FDA) recently approved a new version of BioThrax—the nation's only licensed anthrax vaccine—that requires fewer doses and changes the injection route.

(CIDRAP News) – The federal Advisory Committee on Immunization Practices (ACIP) has opened the door to voluntary anthrax vaccination for first responders, revising an 8-year-old recommendation against that step.

(CIDRAP News) – An interim report from a major study of the US's only licensed anthrax vaccine suggests it may be possible to reduce local side effects without sacrificing effectiveness by changing the injection route and using fewer doses.

(CIDRAP News) – People whose hands may be contaminated by anthrax should wash them with either antimicrobial or conventional soap and water, but should not try to cleanse them with an alcohol-based hand rub, a new study suggests.

(CIDRAP News) – Health and Human Services (HHS) Secretary Tommy G. Thompson has named the 21 members of his Council on Public Health Preparedness, which will advise HHS on dealing with public health emergencies, including bioterrorism.

Federal health authorities provide opportunities in the next month for input as they revise the current policy regarding vaccination of the general population.

(CIDRAP News) – A lengthy report by an expert panel on anthrax generally echoes treatment and prevention recommendations made by federal health officials last fall while highlighting how little is known about the epidemiology of the disease, especially how many spores it takes to cause infection.